Corsicana & Co’s Elevance Health ELV Stock Holding History

Corsicana & Co’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7	Closed	-$3.04K	–	322
2026 Q1	$3.04K	Buy	+7	New	+$2.3K	﹤0.01%	238

Other funds holding ELV

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

AACR

ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return

HGIM

High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

Focused Investors Los Angeles, California $2.96B AUM 15.6% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

Corsicana & Co's ELV Position: Q2 2026 in Review

Corsicana & Co sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 7 shares — an estimated $3.04K sold.

Corsicana & Co first reported a position in ELV in Q1 2026 and held it in 1 quarter. The position peaked at $3.04K in Q1 2026. 735 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Corsicana & Co reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
Corsicana & Co sold 7 Elevance Health shares in Q2 2026, an estimated $3.04K.
Corsicana & Co first reported a position in Elevance Health in Q1 2026 and held it in 1 quarter.
Corsicana & Co's Elevance Health position peaked at $3.04K in Q1 2026.
735 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Corsicana & Co's 13F filing for Q2 2026, filed 24 Jul 2026.